p16INK4a can initiate an autonomous senescence program

被引:120
作者
Dai, CY
Enders, GH
机构
[1] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Cell & Mol Biol Program, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Ctr Canc, Philadelphia, PA 19104 USA
关键词
p16(INK4a); senescence; tumor suppressor; retinoblastoma protein;
D O I
10.1038/sj.onc.1203438
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tumor suppressor p16(INK4a) is a potent mediator of cell cycle arrest in transient expression studies, is induced in senescing cells, and can impose morphological features of senescence, Nonetheless, it is unclear whether p16(INK4a) can block cell proliferation irreversibly. We explored this issue using osteogenic sarcoma cell clones with inducible p16(INK4a) expression. Induction of p16(INK4a) for 1 day arrested most cells in G1 phase. If the induction was then interrupted, p16(INK4a) levels returned to baseline and robust growth resumed within 3-5 days. When p16(INK4a) was induced for 6 days DNA synthesis remained strongly inhibited and the cells acquired morphological features of senescence. Moreover, if p16(INK4a) induction was interrupted at this point and the cells were followed for 12 more days, most cells retained these morphologic features and either failed to divide or died. This occurred despite the prompt return of p16(INK4a) expression and retinoblastoma protein phosphorylation toward baseline levels. In fact, some senescing cells appeared to enter S phase. These results demonstrate that a sustained period of p16(INK4a) expression is sufficient in this setting to impose a durable block to cell proliferation and that this state becomes independent of p16(INK4a) expression, hypophosphorylation of pRB, or a strict G1 arrest.
引用
收藏
页码:1613 / 1622
页数:10
相关论文
共 38 条
[11]   Reinitiation of DNA synthesis and cell division in senescent human fibroblasts by microinjection of anti-p53 antibodies [J].
Gire, V ;
Wynford-Thomas, D .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (03) :1611-1621
[12]   TIGHT CONTROL OF GENE-EXPRESSION IN MAMMALIAN-CELLS BY TETRACYCLINE-RESPONSIVE PROMOTERS [J].
GOSSEN, M ;
BUJARD, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) :5547-5551
[13]   Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1 [J].
Harkin, DP ;
Bean, JM ;
Miklos, D ;
Song, YH ;
Truong, VB ;
Englert, C ;
Christians, FC ;
Ellisen, LW ;
Maheswaran, S ;
Oliner, JD ;
Haber, DA .
CELL, 1999, 97 (05) :575-586
[14]   Expression of p16(INK4a) suppresses the unbounded and anchorage-independent growth of a glioblastoma cell line that lacks p16(INK4a) [J].
Higashi, H ;
SuzukiTakahashi, I ;
Yoshida, E ;
Nishimura, S ;
Kitagawa, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 231 (03) :743-750
[15]  
Jarrard DF, 1999, CANCER RES, V59, P2957
[16]   Features of replicative senescence induced by direct addition of antennapedia-p16INK4A fusion protein to human diploid fibroblasts [J].
Kato, D ;
Miyazawa, K ;
Ruas, M ;
Starborg, M ;
Wada, I ;
Oka, T ;
Sakai, T ;
Peters, G ;
Hara, E .
FEBS LETTERS, 1998, 427 (02) :203-208
[17]   Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells [J].
Kiyono, T ;
Foster, SA ;
Koop, JI ;
McDougall, JK ;
Galloway, DA ;
Klingelhutz, AJ .
NATURE, 1998, 396 (6706) :84-88
[18]   TUMOR-DERIVED P16 ALLELES ENCODING PROTEINS DEFECTIVE IN CELL-CYCLE INHIBITION [J].
KOH, J ;
ENDERS, GH ;
DYNLACHT, BD ;
HARLOW, E .
NATURE, 1995, 375 (6531) :506-510
[19]   RETINOBLASTOMA-PROTEIN-DEPENDENT CELL-CYCLE INHIBITION BY THE TUMOR-SUPPRESSOR P16 [J].
LUKAS, J ;
PARRY, D ;
AAGAARD, L ;
MANN, DJ ;
BARTKOVA, J ;
STRAUSS, M ;
PETERS, G ;
BARTEK, J .
NATURE, 1995, 375 (6531) :503-506
[20]   p16INK4a, but not constitutively active pRb, can impose a sustained G1 arrest:: molecular mechanisms and implications for oncogenesis [J].
Lukas, J ;
Sorensen, CS ;
Lukas, C ;
Santoni-Rugiu, E ;
Bartek, J .
ONCOGENE, 1999, 18 (27) :3930-3935